Learn more

For 17 years, we have enabled global clinical research via mobile visits and our site network, using strategies that speed enrollment, boost retention, and solve complex challenges

section-hero-transparent2x_v2

Section - Hero Transparent@2x_v2

hero-mobile-transparent2x

Hero Mobile Transparent@2x

Results for you.
Science for all.

acf/header

core/spacer

acf/html-code

The EmVenio ARC(H) Platform connects patients, communities, and sponsors through a flexible, human-centered research approach that delivers results without compromise.

ARC(H) represents Access, Reach, Community, and Human-Centered Research—the foundational elements that shape everything we do. Together, they guide our approach to expanding participation, engaging underrepresented populations, and building trusted relationships that last.

Every solution we offer is powered by the ARC(H) Platform. It’s how we deliver clean, reliable data across 80+ countries, maintain industry-leading retention rates, and help our partners unlock the full potential of clinical research.

emvenio-107-2508-rebrand-graphic_arch-graphic

Emvenio-107-2508-Rebrand-Graphic_Arch Graphic

Our Approach

acf/image-text

We bring clinical research directly to patients by deploying Mobile Research Clinicians to homes, workplaces, or other convenient locations.

Mobile Visits

Our network of Research Centers and Community Research Sites brings clinical trials to previously untapped communities, expanding access and participation.

Site Network

We provide personalized support—from transportation to daily logistics—helping patients overcome barriers to participation, improve retention.

Patient Navigator

Key Solutions

acf/thumbnail-grid

With capabilities in over 80+ countries, we can reach more patients while keeping them engaged and retained in your study.

emvenio-109-2508-map-infographic_p3-4

Emvenio-109-2508 Map Infographic_P3 (4)

Global Reach

Overcoming geographical barriers with a presence in 80+ countries—bringing research to where people live.

Trusted by 200+ sponsors who rely on our precision, efficiency, and commitment to quality.

Delivering results across 800+ clinical studies—powered by community insight and scientific rigor.

100,000+ patient visits made possible through empathy, access, and industry-leading retention.

acf/statistics

We combine disciplined processes with human connection. That means confidence and reliability for sponsors, and meaningful experiences for patients.

close-up-of-physician-giving-vaccine-to-elder-woman-in-doctors-office

Close up of physician giving vaccine to elder woman in doctor's office

Operations & Approach

EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants.



DENVER, Colo., Aug. 25, 2025 – PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – EmVenio Clinical Research. This consolidation brings together each company’s unique strengths under one entity to offer sponsors and contract research organizations greater flexibility and global reach. As a division of <a href="https://procasemanagement.com/">Professional Case Management</a>, EmVenio is grounded in a trusted foundation of clinical expertise and compassionate care.



“As we combine three uniquely strong and innovative companies, we are setting a new industry standard for reach, access and precision in community-based clinical research,” said Greg Austin, president of PCM Trials and now serving as president of EmVenio Clinical Research. “Joining forces solely under the EmVenio name will enable us to further succeed in making clinical research more approachable and accessible for participants to enroll and remain in studies. We’re excited for what we will be able to accomplish for future clinical trials across North America, Europe and beyond."



As subsidiaries of Professional Case Management, PCM Trials, EmVenio and Clinical Trial Service provided complementary capabilities, each with distinct service lines. As they align under a unified brand, sponsors can now access a robust solutions platform to drive patient accessibility and participation. EmVenio now operates in over 80 countries, leveraging mobile teams and local research sites to meet participants where they live and work.



EmVenio is also launching a new service offering – Patient Navigator – a personalized support option designed to reduce logistical and financial barriers to clinical trial participation. This added service is especially critical in therapeutic areas where trial participation can be particularly burdensome for patients, such as rare diseases and pediatrics. Aimed at improving patient retention and minimizing dropout rates in trials, Patient Navigator offers flexible participation support, including coordinated travel, lodging and reimbursement assistance, alongside EmVenio’s other solutions such as remote, virtual and community-based visit opportunities. Together, these offerings are designed to meet patients where they are - making trial participation more accessible.



PCM Trials was founded in 2008 and became a global leader in decentralized clinical trials through specialty mobile nurse visits to clinical trial participants’ homes. Many of PCM Trials’ innovations have been adopted as standard practices today for clinical research. In 2024, PCM Trials acquired Clinical Trials Service, followed shortly by the acquisition of EmVenio Research, forming a powerful alliance dedicated to expanding global access to clinical trials.



“As the three organizations come together, EmVenio Clinical Research offers clinical research organizations and sponsors decades of experience, a presence in over 80 countries, and a proven track record of recruiting over 75% minority patients and retaining more than 92% of participants in trials,” Austin said. “Because of this collective success, EmVenio’s brand name best encapsulates our united team’s vision for the future of research. It combines the word ‘empower’ and the Latin word ‘venio’, meaning ‘to reach,’ which directly reflects our mission and strategic direction to reach patients in ways traditional models cannot.”



About EmVenio Clinical Research



EmVenio Clinical Research, a Professional Case Management subsidiary, operates from U.S. and European headquarters with a team of approximately 5,000 professionals supporting clinical trials across more than 80 countries. Our community-based sites and mobile research services expand access for trial participants, while enabling sponsors and CROs to execute high-quality studies at speed and scale with clean, reliable data and consistent results. By bringing trials directly to patients in their homes, communities or places they gather, we enroll populations others miss, helping create a complete and more inclusive picture of human health. Our approach is grounded in empathy, expertise and close collaboration—bridging the gap between science and the people it serves because true progress only happens when research reflects the real world. For more information, please visit <a href="https://emvenio.com/">emvenio.com</a>.

PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research

Welcome to EmVenio Clinical Research – the next era of PCM Trials, EmVenio Research and Clinical Trial Service.



Our new visual identity is now authentically us: warm, welcoming, and human-centered. We’re excited to introduce our new brand – and share the journey that brought us here.



<h4 class="wp-block-heading">How did we get here?</h4>



PCM Trials was founded in 2008 with a clear goal: to make clinical trial participation more accessible for patients, helping bring more therapies to the people who need them all over the world. With the introduction of Certified Mobile Research Nurses (CMRNs), PCM Trials quickly established itself as a trusted leader in home-based clinical trial services.



In 2024, PCM Trials took a major step toward expanding global access to clinical research by acquiring Clinical Trial Service, a Netherlands-based company, bringing a truly global footprint and deep local expertise to reach patients wherever they are. Shortly after, PCM Trials acquired EmVenio Research, further strengthening its ability to bring clinical trials directly into local communities through EmVenio’s network of community-based research sites. In addition to its community-based sites, EmVenio also established a network of brick-and-mortar research centers within existing hospital systems, including the Prime Healthcare network. Each location was strategically selected with local social determinants of health in mind – helping remove barriers to participation and enroll populations that others miss.



Since then, PCM Trials, EmVenio Research, and Clinical Trial Service have combined their unique strengths to build a global clinical research organization that meets patients where they are — in their homes, communities, and places they gather. Together, we've expanded access through mobile visits, community-based research sites, and hospital-embedded locations, making trial participation easier and more inclusive.



To reflect this shared mission and unified approach, we made the joint decision to align our services under one name: EmVenio Clinical Research.



<h4 class="wp-block-heading">Why EmVenio?</h4>



The name EmVenio reflects the shared mission, purpose, and values of PCM Trials, EmVenio Research, and Clinical Trial Service. We began with the word “empower”, because our goal is to empower communities by creating more opportunities for research participation and building trust that keeps patients engaged. We then added “venio,” the Latin word meaning “to reach.” This reflects our mission to extend the reach of clinical research by meeting patients where they are and removing barriers to access through flexible participation options, especially for underserved and underrepresented populations.



Together, ”EmVenio” represents who we are: an organization that empowers and reaches patients where they live and work, removing barriers to participation, and fostering trust and connection throughout the research journey.



<h4 class="wp-block-heading">Results for you. Science for all.</h4>



While our commitment to providing excellent service for our partners remains unchanged, our visual identity has evolved to better reflect who we are and what we stand for. Through warm tones like maroon and amber, we’re breathing new life into an industry that’s often seen as cold and clinical. This isn’t just a design update – it’s a reflection of our belief that science should feel human, inclusive, and alive. Our updated photography highlights what truly makes clinical research possible: the people. From participants in trials to the clinicians, researchers, and principal investigators who conduct them, every breakthrough begins with human connection. Our work wouldn’t be possible without their dedication – and without you.



Our new symbol represents the union of three organizations – PCM Trials, EmVenio, and CTS. Each of its three sides reflects the unified foundation for our shared mission. The shape also resembles a multiplication sign, symbolizing our belief that, together, we can multiply what’s possible in clinical research.



Medical breakthroughs don’t happen by chance – they take time, people, commitment and a determination to go further than before to transform patient outcomes for generations. At EmVenio, we go where others don’t, delivering results for you and science for all.



Our research capabilities span more than 80 countries, allowing us to continually enroll populations that others miss to create a more complete picture for scientific advancement. We deliver clear, reliable data for every project we take on and tailor our research approach to each therapeutic area, successfully enrolling patients from routine to complex populations. From our first conversation, we collaborate closely with partners to &nbsp;understand their goals, constraints, and needs – whatever they may be\. Our goal is to build lasting relationships rooted in trust and empathy, with a deep understanding of both our partners and the patients they serve.



We recognize the humanity behind every data point, allowing us to maintain industry-leading retention rates and deliver the insights our partners rely on. Because the only way to unlock scientific potential for all is to access patient populations to reflect the real world, deliver expertise at every stage, and foster genuine human connection.



Follow EmVenio on <a href="https://www.linkedin.com/company/emvenioresearch/">LinkedIn</a>, <a href="https://www.facebook.com/EmVenio">Facebook</a>, <a href="https://www.instagram.com/emvenio/">Instagram</a> and <a href="https://x.com/EmvenioResearch">X</a> to stay connected and see what's next.

Now introducing: EmVenio Clinical Research

EmVenio is a global leader in clinical research, committed to helping researchers make medical breakthroughs. Delivering consistent results and making research available for all starts with meeting patients where they are—in their homes, in their communities, or where they gather. Through our mobile teams, virtual visits, and local research sites, we achieve precise, reliable data, and consistent results that meet and exceed research goals. We have research capabilities extending over 80 countries, enabling us to continually enroll populations others miss and create a more complete picture for scientific advancement.





<div style="height:100px" aria-hidden="true" class="wp-block-spacer"></div>

EmVenio Puts the Reach in Research

See all

Knowledge Center

acf/latest-news

Contact us

Whether you're a sponsor, CRO, or patient, we're here to meet you where you are—ready to listen, collaborate, and support your journey through clinical research.

Results for you.
Science for all.

Our Approach

Key Solutions

Mobile Visits

Site Network

Patient Navigator

Global Reach

Key Statistics

Operations & Approach

Knowledge Center

PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research

Now introducing: EmVenio Clinical Research

EmVenio Puts the Reach in Research

Let’s Connect

Patients

About Us

Contact

Results for you.Science for all.

Our Approach

Key Solutions

Mobile Visits

Site Network

Patient Navigator

Global Reach

Key Statistics

Operations & Approach

Knowledge Center

PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research

Now introducing: EmVenio Clinical Research

EmVenio Puts the Reach in Research

Let’s Connect

Results for you.
Science for all.